Lymphoma, B-Cell, Marginal Zone - 24 Studies Found
| Completed |
: Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori : Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive : 2010-12-20 : Drug: Rabeprazole Sodium The following 3 drugs are taken o |
| Completed |
: Velcade in MALT Lymphoma Patients : MALT Lymphoma : 2006-09-07 : Drug: Bortezomib (Velcade) |
| Completed |
: Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL) : Marginal Zone B-cell Lymphoma : 2010-07-15 : Drug: Everolimus Everolimus (tablets, 5 mg) is given orally at the dose of 10 mg/day from day 1 to day 2 |
| Active, not recruiting |
: Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma : Marginal Zone B-cell Lymphoma : 2016-07-26 : Drug: Bendamustine and Rituximab |
| Terminated |
: Gemcitabine for Marginal Zone Lymphoma :
: 2006-06-14 : Drug: gemcitabine D1 and 8, Gemcitabine 1250mg/m2 + NS 100ml MIV over 30min, every 3 weeks |
| Active, not recruiting |
: Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment : Marginal Zone Lymphoma of Ocular Adnexal : 2013-03-26 : Drug: Doxycycline All enrolled patients will be treated with doxycycline 100 mg bid daily, orally, for f |
| Active, not recruiting |
: 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma : Relapsed or Refractory Marginal Zone B-cell Lymphoma : 2012-09-04 : Drug: 131I-rituximab |
| Completed |
: Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome : Gastric MALT Lymphoma : 2006-05-17 : Drug: Omeprazole, Amoxicillin, Clarithromycin |
| Active, not recruiting |
: Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma :
: 2013-10-29 : Drug: ibrutinib |
| Terminated |
: Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma :
: 2010-02-11 :
|